Sanofi (LON:0A2V)
London
· Delayed Price · Currency is GBP · Price in USD 55.52
+1.14 (2.11%)
At close: May 2, 2025
Sanofi Statistics
Total Valuation
Sanofi has a market cap or net worth of GBP 93.46 billion. The enterprise value is 102.47 billion.
| Market Cap | 93.46B |
| Enterprise Value | 102.47B |
Important Dates
The last earnings date was Thursday, April 24, 2025.
| Earnings Date | Apr 24, 2025 |
| Ex-Dividend Date | May 9, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.31% |
| Shares Change (QoQ) | -1.57% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.10B |
Valuation Ratios
The trailing PE ratio is 17.74 and the forward PE ratio is 11.04.
| PE Ratio | 17.74 |
| Forward PE | 11.04 |
| PS Ratio | 2.47 |
| PB Ratio | 1.43 |
| P/TBV Ratio | 5.62 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 19.45 |
| EV / Sales | 2.70 |
| EV / EBITDA | 9.66 |
| EV / EBIT | 12.76 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.23 |
| Debt / EBITDA | 1.44 |
| Debt / FCF | n/a |
| Interest Coverage | 17.14 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 6.23% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 455,903 |
| Profits Per Employee | 63,582 |
| Employee Count | 82,878 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +10.75% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +10.75% |
| 50-Day Moving Average | 54.65 |
| 200-Day Moving Average | 53.17 |
| Relative Strength Index (RSI) | 37.56 |
| Average Volume (20 Days) | 10,164 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sanofi had revenue of GBP 37.78 billion and earned 5.27 billion in profits. Earnings per share was 4.22.
| Revenue | 37.78B |
| Gross Profit | 26.81B |
| Operating Income | 7.86B |
| Pretax Income | 6.58B |
| Net Income | 5.27B |
| EBITDA | 10.16B |
| EBIT | 7.86B |
| Earnings Per Share (EPS) | 4.22 |
Balance Sheet
The company has 6.32 billion in cash and 14.99 billion in debt, giving a net cash position of -8.66 billion.
| Cash & Cash Equivalents | 6.32B |
| Total Debt | 14.99B |
| Net Cash | -8.66B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 65.13B |
| Book Value Per Share | 51.72 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 70.96%, with operating and profit margins of 20.80% and 13.95%.
| Gross Margin | 70.96% |
| Operating Margin | 20.80% |
| Pretax Margin | 17.41% |
| Profit Margin | 13.95% |
| EBITDA Margin | 26.90% |
| EBIT Margin | 20.80% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.21, which amounts to a dividend yield of 2.18%.
| Dividend Per Share | 1.21 |
| Dividend Yield | 2.18% |
| Dividend Growth (YoY) | 2.42% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | 0.31% |
| Shareholder Yield | 2.49% |
| Earnings Yield | 5.64% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |